Deepa Manwani
Medical Director, Comprehensive Sickle Cell Disease Program · St Jude Children's Research Hospital
Credentials: · · · · ·
History
PresentComprehensive Sickle Cell Disease Program · St Jude Children's Research Hospital
- 1994–1995
Pediatric Hematology-Oncology
- 1991–1994
Pediatrics
Research
Neutrophil ageing is regulated by the microbiome
Nature · 2015 · 702 citations
Review · Blood · 2016 · 327 citations
Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies
Blood · 2013 · First of 2 authors · 304 citations
20 papers
17 papers
- JK
16 papers
15 papers
12 papers
11 papers
- PF
11 papers
11 papers
Grants
- 2015–2023
Phase 2 Trial of Gamunex ( Intravenous Gammaglobulin) for Sickle Cell Acute Pain
Food and Drug Administration · R01
Contact PI · $1.6M · Albert Einstein College of Medicine
- 2019–2020
National Heart, Lung, and Blood Institute · OT2
Contact PI · $68.5K · Albert Einstein College of Medicine
- 2008–2014
Phase 1-2 Trial of Gamunex (Intravenous Gammaglobulin) for Sickle Cell Acute Pain
Food and Drug Administration · R01
Contact PI · $200K · Albert Einstein College of Medicine
- 2000–2005
Use of Modified Eklf for Gamma Globin Augmentation
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $631.4K · Icahn School of Medicine at Mount Sinai
Clinical trials
- 2014–2044
Sickle Cell Clinical Research and Intervention Program
Principal investigator · Recruiting
St. Jude Children's Research Hospital
- 2012–2016
Bi-Level Positive Airway Ventilation for Acute Chest Syndrome
Principal investigator · Terminated
Albert Einstein College of Medicine